Tag: Deep Vein Thrombosis
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
Negative D-Dimer Can Safely Rule Out DVT as Standalone Test
Standalone D-dimer testing followed by whole-leg compression US in positive patients rules out DVT
Rivaroxaban Prevents VTE After Lower-Limb Surgery
Rivaroxaban superior to enoxaparin for preventing major VTE after nonmajor orthopedic surgery
FDA: Insulin Among Drugs Transitioned to Biological Products
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
Metabolic Syndrome May Up Risk for VTE Recurrence After DVT
Significantly higher odds seen for all four components of MetS, with largest risk increase for hyperlipidemia
Rivaroxaban Cuts Recurrent Blood Clots in Obese Patients
Patients on rivaroxaban also have lower health care resource utilization than those on warfarin
First Anticoagulant Approved for Preventing VTE Recurrence in Children
Boxed warning lists risk for epidural, spinal hematomas with neuraxial anesthesia, spinal puncture
Residual Vein Obstruction Down With Compression After DVT
RVO less likely for those receiving compression within 24 hours of diagnosis of deep vein thrombosis
PCPs Perform Ultrasound for DVT Similarly to Vascular Experts
However, further training could improve general practitioners' sensitivity
Restarting Anticoagulation in Certain VTE Cases Cost-Effective
Treating patients with predicted VTE risk of 17.5 percent or more may be cost-effective
